[2010年至2023年间匈牙利公开资助体外受精程序的利用率]

Dalma Pónusz-Kovács1,2,3, Tímea Molnárné Csákvári1,2,3, Róbert Pónusz1,2,3

  • 11 Pécsi Tudományegyetem, Egészségtudományi Kar, Egészségbiztosítási Intézet Pécs, Vörösmarty u. 3., 7621 Magyarország.

Orvosi hetilap
|July 20, 2025
PubMed
概括

在匈牙利,增加国家资金推动了体外受精 (IVF) 治疗,到2023年患者人数将近三倍. 然而,尽管生育治疗的总体增加,但试管婴儿接入的区域差异仍然很大.

相关概念视频

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
400
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
405
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
184.4K